Manuel Fernandez Pardal
University of Buenos Aires
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Manuel Fernandez Pardal.
Neurology | 1987
Federico Micheli; Manuel Fernandez Pardal; M. Gatto; M. Torres; Guillermo Paradiso; Ignacio Casas Parera; Rolando Giannaula
Cinnarizine and flunarizine are selective calcium blockers that have been used to treat and prevent vertigo. We studied 15 patients who had extrapyrqmidal syndromes after taking these drugs. Eleven patients had parkinsonism, one with persistent akathisia as well; one had an orofacial tremor; one, acute akathisia alone; and one an acute dystonic reaction. All but one improved when the drug therapy was discontinued. Seven patients were also depressed during treatment. Cinnarizine and flunarizine must therefore be added to the list of potentially risky drugs known to induce extrapyramidal reactions and depression.
Clinical Neuropharmacology | 1993
Federico Micheli; Manuel Fernandez Pardal; Mabel Gatto; Jorge Asconapé; Rolando Giannaula; Ignacio Casas Parera
Eight cases of diurnal bruxism (DB) secondary to long-term antidopaminergic drug exposure are reported. Five exhibited a grinding pattern, one a clenching form, and two a mixed type. An odontological etiology was absent throughout. EMG recordings disclosed two distinct patterns of muscle activity, one with brief rhythmic, forceful contractions and the other featuring sustained prolonged contractions. Surface EMG and EEG monitoring during a 24-h period confirmed the absence of bruxism during sleep. Several drug trials failed to provide relief. Our findings support DB as a focal tardive dystonia syndrome.
Neurology | 2016
Gabriela B. Raina; Maria G. Cersosimo; Silvia Folgar; Juan C. Giugni; Cristian Calandra; Juan Pablo Paviolo; Veronica Tkachuk; Carlos Zúñiga Ramírez; Andrea L. Tschopp; Daniela S. Calvo; Luis A. Pellene; Marcela Uribe Roca; Miriam Velez; Rolando Giannaula; Manuel Fernandez Pardal; Federico Micheli
Objective: To describe the clinical features, etiology, findings from neuroimaging, and treatment results in a series of 29 patients with Holmes tremor (HT). Methods: A retrospective study was performed based on review of medical records and videos of patients with HT diagnosis. Results: A total of 16 women and 13 men were included. The mean age at the moment of CNS insult was 33.9 ± 20.1 years (range 8–76 years). The most common causes were vascular (48.3%), ischemic, or hemorrhagic. Traumatic brain injury only represented 17.24%; other causes represented 34.5%. The median latency from lesion to tremor onset was 2 months (range 7 days–228 months). The most common symptoms/signs associated with HT were hemiparesis (62%), ataxia (51.7%), hypoesthesia (27.58%), dystonia (24.1%), cranial nerve involvement (24.1%), and dysarthria (24.1%). Other symptoms/signs were vertical gaze disorders (6.8%), bradykinesia/rigidity (6.8%), myoclonus (3.4%), and seizures (3.4%). Most of the patients had lesions involving more than one area. MRI showed lesions in thalamus or midbrain or cerebellum in 82.7% of the patients. Levodopa treatment was effective in 13 out of 24 treated patients (54.16%) and in 3 patients unilateral thalamotomy provided excellent results. Conclusions: The most common causes of HT in our series were vascular lesions. The most common lesion topography was mesencephalic, thalamic, or both. Treatment with levodopa and thalamic stereotactic lesional surgery seems to be effective.
Clinical Neuropharmacology | 2007
Gabriela B. Raina; Miriam Velez; Manuel Fernandez Pardal; Federico Micheli
We report 2 patients who presented a brainstem hemorrhage and who, after 1 and 6 months, respectively, developed a 4-Hz postural and resting tremor consistent with Holmes tremor, which severely interfered with the activities of daily living. In both cases, levodopa dramatically improved the tremor. Pharmacological treatment of this condition is usually disappointing, and surgical procedures are commonly required for severe cases. Our patients, together with 13 others gleaned from the literature, suggest that in cases of Holmes tremor secondary to brainstem hemorrhage, levodopa can be a useful treatment, and it should be tested before considering invasive therapies.
Clinical Neuropharmacology | 1991
Federico Micheli; Manuel Fernandez Pardal; Emilia Gatto; Guillermo Paradiso
A 19-year-old girl with a long-standing history of kyphoscoliosis misdiagnosed as idiopathic was offered corrective surgery on several occasions but fortunately refused, since neurological examination later found evidence of mild dystonic posturing in the neck and right leg. Symptoms worsened toward evening but improved with rest. Treatment with low doses of levodopa led to total remission within a month. Our case illustrates that dopa-responsive dystonia can manifest spinal curvature as the major symptom and warrants its inclusion in the differential diagnoses of idiopathic kyphoscoliosis.
Parkinsonism & Related Disorders | 2003
Emilia Gatto; Manuel Fernandez Pardal; Federico Micheli
Highly variable phenotype expression has long been recognized in DYT1 carrier patients. We report here an Ashkenazi-Jewish woman who carried a DYT1 mutation and developed a predominant unilateral myoclonic-dystonia (MD) displaying a fluctuating course. The present case is the second supporting the variability of DYT1 phenotype and further illustrates its ability to mimic the MD syndrome.
Clinical Neuropharmacology | 1987
Federico Micheli; Manuel Fernandez Pardal; Roberto de Arbelaiz; Estela Lehkuniec; Rolando Giannaula
A case of a mentally retarded patient with sporadic paroxysmal dystonia, unresponsive to anticonvulsant therapy, is described. He had a longstanding history of neuroleptic drug intake. Trihexyphenidyl in a total daily dosage of 20 mg totally suppressed the crises.
Neurology | 1982
Federico Micheli; Manuel Fernandez Pardal; Ramon Leiguarda
We studied the therapeutic effects of apomorphine, bromocriptine, and lisuride on the dystonic spasms of two patients with Meige disease. Lisuride, a potent dopamine receptor agonist, and apomorphine had equal efficacy in lessening facial dyskinesia, while bromocriptine had no consistent effect. Lisuride can be an excellent drug in the treatment of this disabling disorder.
Neurology | 2007
Federico Micheli; Manuel Fernandez Pardal
We read Dr. van Gerpen’s article in which he reports a patient with camptocormia remarkably responsive to levodopa treatment.1 The authors report that having the patient walk backwards improved the position of the patient’s spine, which was equated to a sensory trick. It was concluded that camptocormia was due to dystonia because of the presence of diurnal fluctuation and …
Movement Disorders | 2001
Emilia Gatto; Manuel Fernandez Pardal; Ricardo Reisin; Ana Pardal
Herein we report a task‐specific dystonia in a 48‐year‐old woman, with an unusual association between a familial harp‐playing dystonia and essential tremor.